Skip to content

Dose Response of Exercise for Arthritis Management

Examination of the Dose Response Relationship Between Physical Activity and Arthritis-Attributable Outcomes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06880653
Acronym
DREAM
Enrollment
285
Registered
2025-03-18
Start date
2025-03-28
Completion date
2029-04-30
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Fibromyalgia (FM), Gout, Lupus Erythematosus, Systemic, Osteoarthritis, Rheumatoid Arthritis (RA)

Keywords

arthritis, exercise, physical activity

Brief summary

The purpose of the study is to see examine the effects of 3 different levels of physical activity (45 minutes/week, 90 minutes/week, or 150 minutes/week) on arthritis symptoms.

Detailed description

All participants will be randomly assigned a physical activity goal (45 min/week, 90 min/week, or 150 min/week). To help participants achieve goals, they will receive a 6 month program which includes the Arthritis Foundation's Walk With Ease Guidebook, behavioral lessons, a Fitbit, and monthly coaching calls. Participants may also receive additional calls, texts, or emails if they are struggling to meet their physical activity goals.

Interventions

BEHAVIORALDREAM Adaptive Intervention

6-month physical activity program (Dose Response of Exercise for Arthritis Management (DREAM)) which includes monthly phone coaching, Walk With Ease Guidebook, behavioral lessons, and a Fitbit. Participants may receive additional contact (email, text, or phone) if they struggle to meet activity goal.

Sponsors

University of South Carolina
Lead SponsorOTHER
Centers for Disease Control and Prevention
CollaboratorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Have a doctor diagnosed form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia * Ability to read and write in English

Exclusion criteria

* Have any contraindications to exercise (besides arthritis) * Engage in \>45 min/week of Actigraph assessed moderate to vigorous intensity activity * Are pregnant, breastfeeding, or planning to become pregnant in the next year * Are planning to relocate out of the Columbia, SC area in the next 12 months, * Do not have a device compatible with Fitbit * Have uncontrolled hypertension (e.g., systolic blood pressure \> 160 mmHg or diastolic blood pressure \> 100 mmHg) * Plan to have a surgery that affects mobility in the next 12 months * Have a serious cognitive impairment. * Not willing to be randomized to any of the 3 conditions, do not believe they could adhere to the goals, or do not believe they could achieve the highest dose of activity (150 minutes/week).

Design outcomes

Primary

MeasureTime frameDescription
Physical function (6 Minute Walk Test)Baseline to 6 monthsChange in distance walked during the 6 minute walk test

Secondary

MeasureTime frameDescription
Physical function (6 Minute Walk Test)Baseline to 12 monthsChange in distance walked during the 6 minute walk test
Physical function (chair stands)Baseline to 6 monthsChange in chair stand repetitions
Health Related Quality of Life - PhysicalBaseline to 6 monthsChange in the physical component score of the SF-12v2 Health Survey. Scores range from 0-100, with higher scores reflective of better health.
Health Related Quality of Life - MentalBaseline to 6 monthsChange in the mental component score of the SF-12v2 Health Survey. Scores range from 0-100, with higher scores reflective of better health.
Pain intensityBaseline to 6 monthsChange in pain as measured by a visual analog scale. Scores range from 0-100, with higher scores reflective of higher pain.
Depression symptomsBaseline to 6 monthsChange in depression symptoms using the CES-D. Scores range from 0-60, with higher scores reflective of more depression symptoms.

Countries

United States

Contacts

CONTACTEllen Wingard
EWINGARD@mailbox.sc.edu803-777-1889
PRINCIPAL_INVESTIGATORChristine Pellegrini, PhD

University of South Carolina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026